| 名稱 | TP53 p.R213* Reference Standard 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP10181 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | TP53 p.R213* Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn)，國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- 細(xì)胞株購(gòu)買為何比較看重生物等級(jí)？
- 【靶點(diǎn)模型】AKT基因的藥物開發(fā)
- NKG2A細(xì)胞篩選模型
- 【論文作者回應(yīng)】小蘇打“餓死”腫瘤？教授為你答疑解惑
- TSHR細(xì)胞模型簡(jiǎn)介
- KIR3DL3/HHLA2細(xì)胞篩選模型
- 重磅！科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- PNAS：腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
- 雙面PD1，Blocker已成卷王，agonist賽道你上車了嗎？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10181TP53 p.R213* Reference Standard 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
CBP10181 | |
| Format | Genomic DNA |
| Description | TP53 R213* results in a premature truncation of the Tp53 protein at amino acid 213 of 393 (UniProt.org). Due to the loss of the much of the DNA binding domain, as well as the tetramerization domain and C-terminal basic domain, R213* is predicted to result in a loss of Tp53 protein function (PMID: 20978130). |
| Technical Data | |
| DNA Change | c.637C>T |
| AA Change | p.R213* |
| Mutation type | Substitution - Missense |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | ENST00000269305 |
| Cosmic ID | COSM10654 |
| Chr position(GRCh37) | chr17:7578212 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)